ArticleClinical and translational medicine2026
Cancer cell-selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy.
Ziyan Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.